Teleflex Inc
TFX: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|?.J@Jy&Mp | LOCK|$Y | LOCK|H! |
Teleflex Earnings: Fair Value Lowered on Disappointing Guidance; Company Will Split by Mid-2026
Teleflex reported fourth-quarter results that were in line with our expectations, but guidance disappointed. We lower our fair value to $200 per share to incorporate lower near-term growth expectations. The company announced its acquisition of Biotronik’s vascular intervention business for about EUR 760 million, which we think can complement Teleflex’s interventional business. Last but not least, the company announced a plan to split into two entities by mid-2026; we await further information in upcoming regulatory filings.
